Meet Orlando Brown, Jr., a hero for T1D advocacy
Orlando Brown, Jr.'s commitment to type 1 diabetes (T1D) advocacy stems from his family’s journey with the disease.
Moving T1D forward through advocacy
Breakthrough T1D Chief Global Advocacy Officer Lynn Starr discusses how type 1 diabetes advocacy drives our mission progress forward...faster.
Transforming Lives, One Step At a Time
Meet three Walk teams that are changing the lives of people with type 1 diabetes, one step at a time.
Putting the Foxes in Charge of the Henhouse: The Dramatic Race to Develop an Artificial Pancreas
The true story of how artificial pancreas systems moved from an idea to a therapy, improving the lives of millions…
Meet Alecia Wesner, a hero for T1D clinical trials
Since 2014, Alecia Wesner has participated in numerous T1D clinical trials, many of which were early artificial pancreas system trials.
Breakthrough T1D Mourns Tragic, Sudden Loss of Five Ride Champions
The leadership, staff, and volunteers of Breakthrough T1D mourn the recent loss of five T1D Champions.
Meet Liz Walsh, a hero for pregnancy with T1D
Thanks to advancements in type 1 diabetes treatment and care, Liz Walsh had a complication-free pregnancy with T1D.
Vertex launches pivotal trial for stem-cell derived islet therapy
On Monday, Vertex made a monumental announcement. Their Phase 1/2 trial for VX-880 is converting to a Phase 1/2/3 pivotal…
Fact-checking myths and misconceptions about type 1 diabetes
We take a look at some of the most common misconceptions about T1D and set the record straight!
FDA Advisory Committee does not recommend that sotagliflozin receive approval for glucose lowering in adults with type 1 diabetes (T1D) and Chronic Kidney Disease (CKD)
Update – November 22, 2024 This morning, Lexicon Pharmaceuticals, Inc. (Lexicon) announced they received a “deficiencies preclude discussion” letter from…
